Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 480.00
Ask: 490.00
Change: 12.50 (2.65%)
Spread: 10.00 (2.083%)
Open: 472.50
High: 489.50
Low: 472.50
Prev. Close: 472.50
MPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Shareholding

4 May 2005 14:50

Molins PLC4 May 2005 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF COMPANY MOLINS PLC 2) NAME OF DIRECTOR DAVID JOHN COWEN 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of an non-beneficial interest SHAREHOLDER 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them. (If notified) DAVID JOHN COWEN 3,219 MICHELE CHRISTINE COWEN 18,000 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) NO 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary REALISATION OF SHARES AWARDED UNDER THE MOLINS PLC LONG TERM INCENTIVE PLAN AND SALE OF SAME. 7) Number of shares/amount of stock acquired 47,247 8) Percentage of issued Class 0.23 9) Number of shares/amount of stock disposed 47,247 10) Percentage of issued Class 0.23 11) Class of security 25p ORDINARY 12) Price per share SHARES ACQUIRED : £NIL SHARES DISPOSED : £1.62338 13) Date of transaction 29 APRIL 2005 14) Date company informed 3 MAY 2005 15) Total holding following this notification 21,219 16) Total percentage holding of issued class following this notification 0.1 IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE THE FOLLOWING BOXES 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number. 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information THESE TRANSACTIONS REPRESENT THE EXERCISE OF A CONDITIONAL GRANT AND SUBSEQUENT SALE OF ORDINARY SHARES FOLLOWING THE SIX YEAR ANNIVERSARY OF A CONDITIONAL GRANT OF SHARES UNDER THE RULES OF THE COMPANY'S LONG-TERM INCENTIVE PLAN. THE PROCEEDS WILL BE PARTIALLY USED TO SATISFY THE ASSOCIATED TAX LIABILITY ARISING FROM THE EXERCISE OF THE AWARD. IN ADDITION TO A BENEFICIAL INTEREST IN 21,219 ORDINARY SHARES, MR COWEN HOLDS CONDITIONAL GRANTS, UNDER THE RULES OF THE LONG-TERM INCENTIVE PLAN, IN 443,762 SHARES, OF WHICH THE PERFORMANCE CRITERIA HAVE BEEN MET IN RESPECT OF 170,762 SHARES. 24) Name of contact and telephone number for queries A L PENNYCUICK 01908 219000 25) Name and signature of authorised company official responsible for making this notification A L PENNYCUICK Date of Notification 4 MAY 2005 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Apr 20247:35 amRNSSiSTEM pilot battery assembly line
17th Apr 20247:00 amRNSLaunch of ESG Report
9th Apr 20241:12 pmRNSGrant of Options
8th Apr 20242:15 pmRNSNotice of AGM
19th Mar 20247:00 amRNSFull Year Results
21st Feb 20247:00 amRNSEquity Development Investor Presentation
16th Feb 20247:00 amRNSNotice of Results
11th Jan 20247:00 amRNSFull Year Trading Update
4th Dec 202311:51 amRNSDirector/PDMR Shareholding
27th Nov 202311:36 amRNSDirector/PDMR Dealing
18th Oct 20232:42 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSAppointment of Joint Broker
22nd Sep 202311:19 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSHalf Year Results
17th Aug 20237:00 amRNSEquity Development Investor Webinar
11th Jul 20237:00 amRNSTrading Update and Notice of Results
30th May 202310:52 amRNSDirector/PDMR Shareholding
18th May 202311:17 amRNSResult of Annual General Meeting
17th May 20237:00 amRNSAGM Statement
2nd May 20234:37 pmRNSDirector/PDMR Transaction
6th Apr 20235:30 pmRNSAvailability of Annual Report and Notice of AGM
27th Mar 202310:53 amRNSDirector/PDMR Dealing
22nd Mar 20237:01 amRNSCEO succession
22nd Mar 20237:00 amRNSFull Year Results
20th Feb 20237:00 amRNSEquity Development Investor Presentation
17th Feb 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSFull Year Trading Update
24th Oct 20222:20 pmRNSDirectorate Appointment
14th Oct 202210:58 amRNSReplacement - PDMR Dealing & Total Voting Rights
12th Oct 20224:59 pmRNSDirector/PDMR Dealing & Total Voting Rights
15th Sep 202212:50 pmRNSMpac signs FREYR framework agreement
13th Sep 20227:00 amRNSEquity Development Investor Presentation
9th Sep 20222:16 pmRNSDirector/PDMR Transaction
8th Sep 20227:00 amRNSHalf Year Result
11th Jul 20227:00 amRNSTrading Update and Notice of Results
24th Jun 20222:54 pmRNSAppointment of new auditor
10th Jun 20224:10 pmRNSGrant of Options
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.